SCHEMBL3115667

SCHEMBL3115667

CC[CH]c1ccccc1[N+](=O)[O-]

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
CA12 O43570 1/20 0.53
MAPT P10636 3/20 0.51
NPSR1 Q6W5P4 1/20 0.51
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
LMNA P02545 2/20 0.50
HSD17B10 Q99714 1/20 0.50
KDM4E B2RXH2 1/20 0.50
THRB P10828 1/20 0.50
PTBP1 P26599 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
XDH P47989 2/20 0.49
SOS1 Q07889 1/20 0.49
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
CYP19A1 P11511 1/20 0.47
MAOB P27338 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1231746 0.87 ALDH1A1 (0.50) ALDH1A1CA12MAPTNPSR1MEN1
SCHEMBL7528494 0.83 ALDH1A1 (0.57) ALDH1A1MAPTMEN1KMT2ASOS1
SCHEMBL7528506 0.83 ALDH1A1 (0.57) ALDH1A1MAPTMEN1KMT2ASOS1
SCHEMBL10149216 0.83 ALDH1A1 (0.57) ALDH1A1MAPTMEN1KMT2ASOS1
SCHEMBL28049747 0.82 CA12 (0.51) ALDH1A1CA12MAPTNPSR1MEN1
SCHEMBL27940186 0.82 CA12 (0.51) ALDH1A1CA12MAPTNPSR1MEN1
SCHEMBL27798771 0.82 MAPT (0.54) ALDH1A1CA12MAPTNPSR1MEN1
SCHEMBL4616304 0.81 CA12 (0.51) ALDH1A1CA12MAPTNPSR1MEN1
SCHEMBL2640285 0.81 CA12 (0.50) ALDH1A1CA12MAPTNPSR1MEN1
2-Nitrobenzaldehyde SCHEMBL28576898 0.79 ERN1 (0.59) ALDH1A1CA12MAPTNPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118048375-A Light-sensitive degradable positive plasmid, construction method and application 郑州纳克智造生物科技有限公司 2024-05-17 CN claimed
EP-3688124-B1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-10-25 EP claimed
EP-3688124-A1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME ExxonMobil Chemical Patents Inc. (US) 2020-08-05 EP claimed
US-10711216-B2 Ester compounds, lubricating oil compositions containing same and processes for making same EXXONMOBIL CHEMICAL PATENTS INC. (US) 2020-07-14 US claimed
CN-111386331-A Ester compound, lubricating oil composition containing same, and method for producing same 埃克森美孚化学专利公司 2020-07-07 CN claimed
US-20190100710-A1 Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same EXXONMOBIL CHEMICAL PATENTS INC. 2019-04-04 US claimed
WO-2019067061-A1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME EXXONMOBIL CHEMICAL PATENTS INC. (US) 2019-04-04 WO claimed
CN-118048375-A Light-sensitive degradable positive plasmid, construction method and application 郑州纳克智造生物科技有限公司 2024-05-17 CN disclosed
EP-3717501-B1 PHOTOCLEAVABLE NUCLEOTIDE REAGENTS WITH HIGH STABILITY ROCHE DIAGNOSTICS GMBH (DE) 2024-03-06 EP disclosed
EP-3676240-B1 ESTER COMPOUNDS AND LUBRICATING OIL COMPOSITIONS CONTAINING SAME EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-11-01 EP disclosed
EP-3688124-B1 ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-10-25 EP disclosed
CN-111032613-B Ester compound, lubricating oil composition containing the same, and method for producing the same 埃克森美孚化学专利公司 2023-03-28 CN disclosed
US-11078534-B2 Photocleavable nucleotide reagents with high stability ROCHE MOLECULAR SYSTEMS, INC. (US) 2021-08-03 US disclosed
WO-2010059711-A1 SIGMA-1 RECEPTOR LIGANDS AND METHODS OF USE WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2010-05-27 WO disclosed
US-20090131352-A1 Aptamers comprising arabinose modified nucleotides MCGILL UNIVERSITY (CA) 2009-05-21 US disclosed
EP-1931694-A1 APTAMERS COMPRISING ARABINOSE MODIFIED NUCLEOTIDES McGILL UNIVERSITY (CA) 2008-06-18 EP disclosed
EP-1928845-A2 AMINODIAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS Array Biopharma, Inc. (US) 2008-06-11 EP disclosed
WO-2007038869-A1 APTAMERS COMPRISING ARABINOSE MODIFIED NUCLEOTIDES MCGILL UNIVERSITY (CA) 2007-04-12 WO disclosed
WO-2007040840-A2 AMINODIAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS ARRAY BIOPHARMA INC. (US) 2007-04-12 WO disclosed
WO-2005105257-A1 CHROMATOGRAPHIC STATIONARY PHASE FOR SEPARATION OF CYCLODEXTRINE AND DERIVATIVES THEREOF CHIROQUEST KIRÁLIS TECHNOLÓGIÁKAT FEJLESZTÖ KFT. (HU) 2005-11-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078534-B2 Photocleavable nucleotide reagents with high stability POLRMT, RNGTT, NUDT1 ALDH1A1 1014/4885CA12 4160/4885MAPT 2418/4885
US-10711216-B2 Ester compounds, lubricating oil compositions containing same and processes for making same ELOVL1, NOTUM, ELOVL5 ALDH1A1 476/4885CA12 1362/4885MAPT 1710/4885
US-20190100710-A1 Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same ELOVL1, NOTUM, ELOVL5 ALDH1A1 476/4885CA12 1362/4885MAPT 1710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.